Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

JF Gainor, L Dardaei, S Yoda, L Friboulet, I Leshchiner… - Cancer discovery, 2016 - AACR
Advanced, anaplastic lymphoma kinase (ALK)–positive lung cancer is currently treated with
the first-generation ALK inhibitor crizotinib followed by more potent, second-generation ALK …
被引用次数：1119 相关文章
[HTML] nih.gov

[HTML][HTML] Molecular Mechanisms of Resistance to First-and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

JF Gainor, L Dardaei, S Yoda, L Friboulet… - Cancer …, 2016 - ncbi.nlm.nih.gov
Advanced, anaplastic lymphoma kinase (ALK)-positive lung cancer is currently treated with
the first-generation ALK inhibitor crizotinib followed by more potent, second-generation ALK …

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors inALK-Rearranged Lung Cancer

JF Gainor, L Dardaei, S Yoda, L Friboulet… - Cancer …, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Advanced, anaplastic lymphoma kinase (ALK)–
positive lung cancer is currently treated with the first-generation ALK inhibitor crizotinib …

Molecular Mechanisms of Resistance to First-and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

JF Gainor, L Dardaei, S Yoda, L Friboulet… - Cancer …, 2016 - europepmc.org
Advanced, anaplastic lymphoma kinase (ALK)-positive lung cancer is currently treated with
the first-generation ALK inhibitor crizotinib followed by more potent, second-generation ALK …

Molecular Mechanisms of Resistance to First-and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

JF Gainor, L Dardaei, S Yoda, L Friboulet… - Cancer …, 2016 - pubmed.ncbi.nlm.nih.gov
Advanced, anaplastic lymphoma kinase (ALK)-positive lung cancer is currently treated with
the first-generation ALK inhibitor crizotinib followed by more potent, second-generation ALK …

[引用][C] Molecular mechanisms of resistance to first-and second-generation ALK inhibitors in ALK-rearranged lung cancer

J Gainor, L Dardaei, S Yoda, L Friboulet… - European Journal of …, 2016 - infona.pl
Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged
lung cancer × Close The Infona portal uses cookies, ie strings of text saved by a browser on …

Molecular Mechanisms of Resistance to First-and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

JF Gainor, L Dardaei, S Yoda, L Friboulet… - Cancer …, 2016 - europepmc.org
Advanced, anaplastic lymphoma kinase (ALK)-positive lung cancer is currently treated with
the first-generation ALK inhibitor crizotinib followed by more potent, second-generation ALK …